antibodies

The immunoassay can be used to monitor cancer cell remnants in a patient's body and help determine which patients need less invasive treatment.

The test measures the level of antibodies to the spike protein of the virus and can be used to establish immunity and vaccine efficacy.

The panel, which includes three immunoassays, identifies the infection stage of the Epstein-Barr virus from a blood sample.

The test measures IgG antibodies directed to the spike protein of the virus and has demonstrated 99.9 percent specificity and 98.9 percent sensitivity.

The lateral flow test is designed to detect immunoglobulin G antibodies against SARS-CoV-2 in a finger prick blood sample and returns results in 20 minutes.

Leinco will use the antibodies for diagnostic applications and will make the antibodies commercially available as part of their research tools catalog.

The test detects IgG antibodies in human serum and plasma and is intended to help identify people with an adaptive immune response to the virus.

Atrys Health will offer and distribute Kantaro's SARS-CoV-2 IgG antibody test kits in parts of Europe and South America.

The test will be available on Abbott's Architect and Alinity I platforms and quantitatively measures the number of antibodies a patient has.